GlassScriptPhysician profile
Thad R Denehy
NPI 1912904756
$4,924.82
in general payments reported to CMS, 2019-2025
41 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $67.93 · 2021: $544 · 2022: $1,625 · 2023: $808 · 2024: $656 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,301 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.15 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,253.00 | 2022 | |
| Hologic Sales and Service, LLC | $495.90 | 2023-2025 | Acessa Provu System, Coolseal Generator, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astrazeneca Pharmaceuticals LP | $411.20 | 2019-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $339.49 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Applied Medical Resources Corporation | $241.98 | 2021 | |
| Dilon Technologies, INC. | $202.45 | 2023 | Hemoblast Bellows |
| Millicent US INC | $165.49 | 2019-2023 | Femring, Intrarosa |
| Biom'Up France Sas | $163.69 | 2021 | |
| Astellas Pharma US INC | $158.82 | 2024-2025 | Veozah |
| Abbvie INC. | $156.85 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Tempus Ai, INC | $146.25 | 2024-2025 | Xt Cdx |
| Glaxosmithkline, LLC. | $126.25 | 2021-2025 | Jemperli, Zejula |
| Sumitomo Pharma America, INC. | $100.14 | 2023-2025 | Myfembree |
| Mimedx Group, INC. | $90.69 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $88.64 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $85.51 | 2023-2024 | Channel Drain, Arista Ah Flexitip |
| Therapeuticsmd, INC. | $72.62 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $50.96 | 2023-2024 | Caldolor |
| Becton, Dickinson and Company | $50.58 | 2024 | Channel Drain |
| Caris Mpi, INC. | $49.03 | 2025 | Mi Cancer Seek |
| Ethicon US, LLC | $47.53 | 2022-2024 | Harmonic, Stratafix, Vistaseal |
| Vertical Pharmaceuticals, LLC | $44.97 | 2019 | |
| Myovant Sciences INC. | $43.64 | 2022 | |
| Medtronic, INC. | $33.70 | 2025 | Absorbatack |
| Vertex Pharmaceuticals Incorporated | $31.53 | 2025 | |
| Olympus America INC. | $28.57 | 2024 | Olympus |
| Avion Pharmaceuticals | $27.75 | 2022 | |
| Axonics, INC. | $25.99 | 2023 | Bulkamid, Axonics |
| Eisai INC. | $20.12 | 2024 | |
| Pfizer INC. | $17.06 | 2024 | |
| Escala Medical INC. | $16.46 | 2025 | |
| Lsi Solutions INC | $15.61 | 2019 | |
| Heron Therapeutics, INC. | $15.49 | 2024 | Aponvie |
| Meditrina | $15.20 | 2025 | |
| Tesaro, INC. | $15.14 | 2019 | |
| Teleflex LLC | $14.13 | 2021 | |
| Immunogen, INC. | $13.81 | 2024 | Elahere |
| Bayer Healthcare Pharmaceuticals INC. | $13.63 | 2019 | |
| Intuitive Surgical, INC. | $12.26 | 2019 | |
| Minerva Surgical, INC | $11.35 | 2019 | |
| Channel Medsystems, INC. | $11.34 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thad Denehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.